1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThe ALS Scholars Program - ALS Scholars in Therapeutics is sponsored by The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital in partnership with ALS Finding a Cure® (ALSFAC) and FightMND. This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
ALS Scholars in Therapeutics: Request for Applicants – ALS Finding a Cure® ALS Scholars in Therapeutics: Request for Applicants ALS Scholars in Therapeutics: Request for Applicants Please forward the announcement below to your network of clinical and basic researchers. Due date for nominations is April 29, 2022 The Sean M.
Healey & AMG Center for ALS at Massachusetts General Hospital (MGH) in partnership with ALS Finding a Cure® (ALSFAC) and FightMND is issuing a request for applications for the ALS Scholars in Therapeutics Program to empower young investigators to learn how to develop new treatments for people living with ALS. Full announcement can be found here .
This two-year program is designed to engage clinician-scientists and post-doctoral fellows to gain training and experience in therapy development for ALS at their home institution with an optional industry experience in year two. All ALS Scholars will be part of the broader ALS global community.
We believe strongly in identifying, supporting, and mentoring the next generation of researchers and are continuing this tradition through the ALS Scholars in Therapeutics Program. ALS Scholars will be an integral member of the Healey & AMG Center for ALS at Mass General and will benefit from mentorship by world renowned scientists and clinicians.
While working closely with their mentors at their home institution, the Scholars will also attend Healey Center and ALSFAC meetings and learn first-hand current approaches to therapy development. Importantly, Scholars will have the opportunity to engage directly with people living with ALS.
In addition, successful candidates interested in understanding the drug development process from an industry perspective, will benefit from an optional six-month internship in industry during the second year of their scholarship. Meet the 2021 Scholars here. 2 years of funding to support a clinician-scientist or post-doctoral fellow working in the ALS field anywhere in the world.
$150,000 award/funding year Recipient must commit at least 75% effort to the proposed ALS research plan Applications from clinician scientists and postdoctoral fellows focused on translational research. Candidates with Ph. D.
or M. D. with strong publication record.
International applicants are encouraged to apply. The ALS focused proposal must have a strong scientific rationale and should be largely developed by the fellow with guidance from his/her mentor. Eligibility for this award is based on the date the candidate attained their degree/qualification.
For MDs, scholars will be considered if they have completed their specialist qualification (i.e., US Residency; Fellowship of the Royal Australasian College of Physicians, etc.) For PhDs, they can be no more than 5 years post-degree.
Release of RFA: March 2, 2022 Applications Due: April 29, 2022 Notification of Award: June 2022 Initiation of Award*: July 1, 2022 (flexible once contracts signed) *Note: Once the award has been finalized the Healey Center for ALS will work with the successful candidate to secure an industry internship in the second year of the fellowship. For queries contact: HealeyCenterforALS@mgh. harvard.
edu To download an application form: click here Submit Application as a single PDF document to HealeyCenterforALS@mgh. harvard. edu Anne D Pham 2022-04-06T14:01:09+00:00
According to the current listing, eligibility includes: Clinician-scientists and post-doctoral fellows. Confirm the full requirements in the official notice before applying.
The current listing shows $150,000 USD per year (inclusive of direct and maximum 15% indirect costs) for a maximum of 2 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The ALS Scholars Program - ALS Scholars in Therapeutics is funded by The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital in partnership with ALS Finding a Cure® (ALSFAC) and FightMND. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Cummings Foundation grew its annual local program from $30 million to $35 million for 2026 awards, but the dollar increase is the smaller story. Nearly every grant now flows as unrestricted general operating support — the funding nonprofits ask for most and receive least. For eligible Massachusetts organizations, the 2027 cycle opens July 15 with a September 16 letter-of-inquiry deadline. Here is who qualifies, why the shift to operating support changes the calculus, and how a small nonprofit should approach a program that hands out 150 grants a year, most of them chosen by community volunteers.
Read articleThe Cummings Foundation's flagship program will award $35 million to roughly 150 eastern-Massachusetts nonprofits in 2027, up from $30 million — and nearly all of it now flows as unrestricted general operating support. Letters of Inquiry opened July 15 and close September 16, 2026. Here is who qualifies, how the multi-year and 10-year tracks work, and how to write an LOI that survives the first cut.
Read articleCummings Foundation raised its annual local grant program from $30M to $35M and is now awarding nearly all of it as unrestricted general operating support — including 25 grants paid over a full 10 years. Letters of inquiry for the 2027 cycle opened July 15 and close September 16, 2026. Here is who qualifies, how the multi-year structure works, and why the shift to unrestricted, decade-long funding matters more than the dollar increase.
Read article